These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25533326)

  • 1. Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.
    Torres AG; Gregory AE; Hatcher CL; Vinet-Oliphant H; Morici LA; Titball RW; Roy CJ
    Vaccine; 2015 Jan; 33(5):686-92. PubMed ID: 25533326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.
    Gregory AE; Judy BM; Qazi O; Blumentritt CA; Brown KA; Shaw AM; Torres AG; Titball RW
    Nanomedicine; 2015 Feb; 11(2):447-56. PubMed ID: 25194998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel O-polysaccharide based glycoconjugates for immunization against glanders.
    Burtnick MN; Heiss C; Schuler AM; Azadi P; Brett PJ
    Front Cell Infect Microbiol; 2012; 2():148. PubMed ID: 23205347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.
    Ulrich RL; Amemiya K; Waag DM; Roy CJ; DeShazer D
    Vaccine; 2005 Mar; 23(16):1986-92. PubMed ID: 15734072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders.
    Burtnick MN; Heiss C; Roberts RA; Schweizer HP; Azadi P; Brett PJ
    Front Cell Infect Microbiol; 2012; 2():108. PubMed ID: 22912938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.
    Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A
    Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Burkholderia mallei and pseudomallei vaccines.
    Silva EB; Dow SW
    Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders.
    Hatcher CL; Mott TM; Muruato LA; Sbrana E; Torres AG
    Infect Immun; 2016 Aug; 84(8):2345-54. PubMed ID: 27271739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model.
    Fernandes PJ; Guo Q; Waag DM; Donnenberg MS
    Infect Immun; 2007 Jun; 75(6):3027-32. PubMed ID: 17403869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei.
    Waag DM; Chance TB; Trevino SR; Rossi FD; Fetterer DP; Amemiya K; Dankmeyer JL; Ingavale SS; Tobery SA; Zeng X; Kern SJ; Worsham PL; Cote CK; Welkos SL
    Microb Pathog; 2021 Jun; 155():104919. PubMed ID: 33915206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.
    Treviño SR; Permenter AR; England MJ; Parthasarathy N; Gibbs PH; Waag DM; Chanh TC
    Infect Immun; 2006 Mar; 74(3):1958-61. PubMed ID: 16495574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice.
    Amemiya K; Meyers JL; Trevino SR; Chanh TC; Norris SL; Waag DM
    Vaccine; 2006 Feb; 24(9):1413-20. PubMed ID: 16213631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
    Titball RW; Burtnick MN; Bancroft GJ; Brett P
    Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
    Bondi SK; Goldberg JB
    Expert Rev Vaccines; 2008 Nov; 7(9):1357-65. PubMed ID: 18980539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine Development.
    Mott TM; Vijayakumar S; Sbrana E; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2015; 9(6):e0003863. PubMed ID: 26114445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of
    Dyke JS; Huertas-Diaz MC; Michel F; Holladay NE; Hogan RJ; He B; Lafontaine ER
    Virulence; 2020 Dec; 11(1):1024-1040. PubMed ID: 32799724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.